Cost-benefit analysis and prenatal diagnosis

A review of key terminology and definitions used for birth defects globally.

Journal of community genetics·2023

Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide.

Journal of community genetics·2018

Addressing key issues in the consanguinity-related risk of autosomal recessive disorders in consanguineous communities: lessons from a qualitative study of British Pakistanis.

Journal of community genetics·2015

A Toolkit to assess health needs for congenital disorders in low- and middle-income countries: an instrument for public health action.

Journal of public health (Oxford, England)·2013

Examining the family-centred approach to genetic testing and counselling among UK Pakistanis: a community perspective.

Journal of community genetics·2012

Epidemiology of oral clefts 2012: an international perspective.

Frontiers of oral biology·2012

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Health economics review·2026

Fever of unknown origin: cost of illness study.

Open medicine (Warsaw, Poland)·2026

The potential usefulness of health asset valuation to promote health among Korean employees.

Scientific reports·2026

Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation Patients at Very High Risk of Stroke: A Budget Impact Analysis in Italy.

Journal of clinical medicine·2026

Hospitalization costs and out-of-pocket expenses for stroke patients in mainland China.

BMC health services research·2026

[Economic evaluation in the health sector: The link between economic and health variables].

Revista medica del Instituto Mexicano del Seguro Social·2026

Related Experiment Videos

Cost-benefit analysis and prenatal diagnosis

Related Concept Videos

A review of key terminology and definitions used for birth defects globally.

Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide.

Addressing key issues in the consanguinity-related risk of autosomal recessive disorders in consanguineous communities: lessons from a qualitative study of British Pakistanis.

A Toolkit to assess health needs for congenital disorders in low- and middle-income countries: an instrument for public health action.

Examining the family-centred approach to genetic testing and counselling among UK Pakistanis: a community perspective.

Epidemiology of oral clefts 2012: an international perspective.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

Fever of unknown origin: cost of illness study.

The potential usefulness of health asset valuation to promote health among Korean employees.

Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation Patients at Very High Risk of Stroke: A Budget Impact Analysis in Italy.

Hospitalization costs and out-of-pocket expenses for stroke patients in mainland China.

[Economic evaluation in the health sector: The link between economic and health variables].

Related Experiment Videos

Cost-benefit analysis and prenatal diagnosis

Related Concept Videos

Related Articles